Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Glycaemic control during the COVID-19 pandemic: A catastrophe or a sign of hope for the person with type 1 Diabetes Mellitus?
Diogo Ramalho; Ana Rouxinol-Dias; Patrícia Tavares; Sara Correia; Lúcia Almeida; Helena Alves; Gustavo Rocha; Maria João Oliveira;
Endocrinol Diabetes Nutr. 2022;69:476-82
Executive Summary from Expert consensus on effectiveness and safety of iDPP-4 in the treatment of patients with diabetes and COVID-19
Francisco Javier Carrasco-Sánchez; Enrique Carretero-Anibarro; Manuel Ángel Gargallo; Ricardo Gómez-Huelgas; Juan Francisco Merino-Torres; Domingo Orozco-Beltrán; Pedro José Pines Corrales; Manuel Antonio Ruiz Quintero;
Endocrinol Diabetes Nutr. 2022;69:209-18
Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study
Fernando Gómez-Peralta; Edelmiro Menéndez; Santiago Conde; Ignacio Conget; Anna Novials;
Endocrinol Diabetes Nutr. 2021;68:642-53